The DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index.
High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi
Open accessPublished version of a preprint
Abstract
Background : In low-income countries, like Malawi, important public health measures including social distancing or a lockdown have been challenging to implement owing to socioeconomic constraints, leading to predictions that the COVID-19 pandemic would progress rapidly. However, due to limited capacity to test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, there are no reliable estimates of the true burden of infection and death. We, therefore, conducted a SARS-CoV-2 serosurvey amongst health care workers (HCWs) in Blantyre city to estimate the cumulative incidence of SARS-CoV-2 infection in urban Malawi. Methods : We recruited 500 otherwise asymptomatic HCWs from Blantyre City (Malawi) from 22 nd May 2020 to 19 th June 2020 and serum samples were collected from all participants. A commercial ELISA was used to measure SARS-CoV-2 IgG antibodies in serum. Results : A total of 84 participants tested positive for SARS-CoV-2 antibodies. The HCWs with positive SARS-CoV-2 antibody results came from different parts of the city. The adjusted seroprevalence of SARS-CoV-2 antibodies was 12.3% [CI 8.2 - 16.5]. Using age-stratified infection fatality estimates reported from elsewhere, we found that at the observed adjusted seroprevalence, the number of predicted deaths was eight times the number of reported deaths. Conclusions : The high seroprevalence of SARS-CoV-2 antibodies among HCWs and the discrepancy in the predicted versus reported deaths suggests that there was early exposure but slow progression of COVID-19 epidemic in urban Malawi. This highlights the urgent need for development of locally parameterised mathematical models to more accurately predict the trajectory of the epidemic in sub-Saharan Africa for better evidence-based policy decisions and public health response planning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
ggmap: Spatial Visualization with ggplot2
Kahle, D. J., & Wickham, H. (2013) · The R Journal · doi:10.32614/rj-2013-014 · Cited by 2,126
Walker, P. G. T., Whittaker, C., Watson, O. J., Baguelin, M., Winskill, P., Hamlet, A., Djafaara, B. A., Cucunubá, Z., Olivera Mesa, D., Green, W., et al. (2020) · Science · doi:10.1126/science.abc0035 · Cited by 993
Lai, X., Wang, M., Qin, C., Tan, L., Ran, L., Chen, D., Zhang, H., Shang, K., Chen, X., Wang, S., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.9666 · Cited by 447
den Bergh, M. K.-V., Buiting, A. G. M., Pas, S. D., Bentvelsen, R. G., van den Bijllaardt, W., van Oudheusden, A. J. G., van Rijen, M. M. L., Verweij, J. J., Koopmans, M., & Kluytmans, J. A. J. W. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.9673 · Cited by 372
COVID-19: PCR screening of asymptomatic health-care workers at London hospital
Treibel, T. A., Manisty, C., Burton, M., McKnight, Á., Lambourne, J., Augusto, J. B., Couto‐Parada, X., Cutiño‐Moguel, T., Noursadeghi, M., & Moon, J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31100-4 · Cited by 314
Exact confidence limits for prevalence of a disease with an imperfect diagnostic test
Reiczigel, J., Foldi, J., & Ózsvári, L. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810000385 · Cited by 208
Why is There Low Morbidity and Mortality of COVID-19 in Africa?
Njenga, M. K., Dawa, J., Nanyingi, M. O., Gachohi, J. M., Ngere, I., Letko, M. C., Otieno, C., Gunn, B. M., & Osoro, E. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0474 · Cited by 175
Larremore, D. B., Fosdick, B. K., Bubar, K. M., Zhang, S., Kissler, S. M., Metcalf, C. J. E., Buckee, C. O., & Grad, Y. H. (2021) · eLife · doi:10.7554/elife.64206 · Cited by 95
Cited by
Sorted by citations
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
Uyoga, S., Adetifa, I. M. O., Karanja, H. K., Nyagwange, J., Tuju, J., Wanjiku, P., Aman, R., Mwangangi, M., Amoth, P., Kasera, K., et al. (2021) · Science · doi:10.1126/science.abe1916 · Cited by 328
Galanis, P., Vraka, I. S., Fragkou, D., Bilali, A., & Καϊτελίδου, Δ. (2020) · Journal of Hospital Infection · doi:10.1016/j.jhin.2020.11.008 · Cited by 323
Mulenga, L. B., Hines, J. Z., Fwoloshi, S., Chirwa, L., Siwingwa, M., Yingst, S., Wolkon, A., Barradas, D. T., Favaloro, J., Zulu, J. E., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00053-x · Cited by 149
Wamai, R. G., Hirsch, J. L., Damme, W. V., Alnwick, D. J., Bailey, R. C., Hodgins, S., Alam, U., & Anyona, R. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168638 · Cited by 113
Variation in SARS-CoV-2 outbreaks across sub-Saharan Africa
Rice, B. L., Annapragada, A. V., Baker, R. E., Bruijning, M., Dotse‐Gborgbortsi, W., Mensah, K., Miller, I. F., Motaze, N. V., Raherinandrasana, A. H., Rajeev, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01234-8 · Cited by 101
Musa, H. H., Musa, T. H., Musa, I. H., Musa, I. H., Ranciaro, A., & Campbell, M. C. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.1456 · Cited by 88
Fear of COVID‐19 and stigmatization towards infected people among Jordanian people
Abuhammad, S., Alzoubi, K. H., & Khabour, O. F. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13899 · Cited by 86
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201
Wiens, K. E., Mawien, P. N., Rumunu, J. P., Slater, D., Jones, F. K., Moheed, S., Caflisch, A. C., Bior, B. K., Jacob, I. A., Lako, R. L. L., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2706.210568 · Cited by 77
Emmerich, P., Murawski, C., Ehmen, C., von Possel, R., Pekarek, N., Oestereich, L., Duraffour, S., Pahlmann, M., Struck, N. S., Eibach, D., et al. (2021) · Tropical Medicine & International Health · doi:10.1111/tmi.13569 · Cited by 72
The coronavirus pandemic and food security: Evidence from Mali
Adjognon, G. S., Bloem, J. R., & Sanoh, A. (2021) · Food Policy · doi:10.1016/j.foodpol.2021.102050 · Cited by 72
Swank, Z., Michielin, G., Yip, H. M., Cohen, P., Andrey, D. O., Vuilleumier, N., Kaiser, L., Eckerle, I., Meyer, B., & Maerkl, S. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025289118 · Cited by 65
SARS-CoV-2 Antibody Seroprevalence and Associated Risk Factors in an Urban District in Cameroon
Nwosu, K. O. S., Fokam, J., Wanda, F., Mama, L., Orel, E., Ray, N., Meke, J., Tassegning, A., Takou, D., Mimbe, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25946-0 · Cited by 59
Barrie, M. B., Lakoh, S., Kelly, J. D., Kanu, J. S., Squire, J. S., Koroma, Z., Bah, S., Sankoh, O. A., Brima, A. S., Ansumana, R., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-007271 · Cited by 59
Mandolo, J., Msefula, J., Henrion, M. Y. R., Brown, C., Moyo, B., Samon, A., Moyo-Gwete, T., Makhado, Z., Ayres, F., Motlou, T., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02187-y · Cited by 61
“This was performed following the manufacturer’s instructions as reported previously [5].”
MethodSelf-citationUmviligihozo, G., Mupfumi, L., Sonela, N., Naicker, D., Obuku, E. A., Koofhethile, C. K., Mogashoa, T., Kapaata, A. A., Ombati, G., Michelo, C. M., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16070.2 · Cited by 60
Ngere, I., Dawa, J., Hunsperger, E., Otieno, N. A., Masika, M., Amoth, P., Makayotto, L., Nasimiyu, C., Gunn, B. M., Nyawanda, B. O., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.08.062 · Cited by 57
Umviligihozo, G., Mupfumi, L., Sonela, N., Naicker, D., Obuku, E. A., Koofhethile, C. K., Mogashoa, T., Kapaata, A. A., Ombati, G., Michelo, C. M., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16070.3 · Cited by 56
Nkuba, A. N., Makiala, S. M., Guichet, E., Tshiminyi, P. M., Bazitama, Y. M., Yambayamba, M. K., Kazenza, B. M., Kabeya, T. M., Matungulu, E. B., Baketana, L. K., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab515 · Cited by 51
High SARS-CoV-2 Seroprevalence in Healthcare Workers in Bukavu, Eastern Democratic Republic of Congo
Mukwege, D. M., Byabene, A., Akonkwa, E. M., Dahma, H., Dauby, N., Cikwanine, J. P. B., Coadou, A. L., Montesinos, I., Bruyneel, M., Cadière, G., et al. (2021) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-1526 · Cited by 52
Knowledge, risk perceptions, and behaviors related to the COVID-19 pandemic in Malawi
Banda, J., Dube, A. L. N., Brumfield, S., Amoah, A. S., Crampin, A. C., Reniers, G., & Helleringer, S. (2021) · Demographic Research · doi:10.4054/demres.2021.44.20 · Cited by 49
The health policy response to COVID-19 in Malawi
Mzumara, G. W., Chawani, M. S., Sakala, M., Mwandira, L., Phiri, E., Milanzi, E. B., Phiri, M. D., Chiumia, I. K., O’Byrne, T., Zulu, E. M., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-006035 · Cited by 52
Quashie, P. K., Mutungi, J. K., Dzabeng, F., Oduro‐Mensah, D., Opurum, P. C., Tapela, K., Udoakang, A. J., WACCBIP COVID-19 Team, Asante, I. A., Paemka, L., et al. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16890.1 · Cited by 47
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
Adetifa, I. M. O., Uyoga, S., Gitonga, J. N., Mugo, D., Otiende, M., Nyagwange, J., Karanja, H. K., Tuju, J., Wanjiku, P., Aman, R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24062-3 · Cited by 67
Seroprevalence surveys in sub-Saharan Africa: what do they tell us?
Usuf, E., & Roca, A. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00092-9 · Cited by 43
Chibwana, M. G., Jere, K. C., Kamng’ona, R., Mandolo, J. J., Katunga-Phiri, V., Tembo, D. L., Mitole, N., Musasa, S., Sichone, S., Lakudzala, A. E., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16188.2 · Cited by 48
Self-citationLapidus, S., Liu, F., Casanovas‐Massana, A., Dai, Y., Huck, J. D., Lucas, C. G. D. O., Klein, J., Filler, R. B., Strine, M. S., Sy, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-26709-7 · Cited by 48
Barnes, K. G., Levy, J. I., Gauld, J., Rigby, J., Kanjerwa, O., Uzzell, C. B., Chilupsya, C., Anscombe, C., Tomkins-Tinch, C. H., Mbeti, O., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43047-y · Cited by 43
Self-citationKalungi, A., Kinyanda, E., Akena, D. H., Kaleebu, P., & Bisangwa, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.565625 · Cited by 38
Systematic review of productivity loss among healthcare workers due to Covid‐19
Yaghoubi, M., Salimi, M., & Amiri, M. (2021) · The International Journal of Health Planning and Management · doi:10.1002/hpm.3351 · Cited by 42
Cost-effectiveness of Coronavirus Disease 2019 Vaccination in Low- and Middle-Income Countries
Siedner, M. J., Alba, C., Fitzmaurice, K. P., Gilbert, R. F., Scott, J. A., Shebl, F. M., Ciaranello, A. L., Reddy, K. P., & Freedberg, K. A. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac243 · Cited by 44
SARS-CoV-2 Infection in Ivory Coast: A Serosurveillance Survey among Gold Mine Workers
Milleliri, J., Coulibaly, D., Nyobe, B., Rey, J., Lamontagne, F., Hocqueloux, L., Giachè, S., Valéry, A., & Prazuck, T. (2021) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.21-0081 · Cited by 28
Batchi-Bouyou, A. L., Ingoba, L. L., Ndounga, M., Vouvoungui, J. C., Mapanguy, C. C. M., Boumpoutou, R. K., & Ntoumi, F. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.12.065 · Cited by 25
SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in Nigeria
Kolawole, O. M., Tomori, O., Agbonlahor, D. E., Ekanem, E., Bakare, R. A., Abdulsalam, N., Okojie, O. H., Braide, E. I., Uzochukwu, B. S. C., Rafindadi, A., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.36053 · Cited by 26
SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis
Azami, M., Moradi, Y., Moradkhani, A., & Aghaei, A. (2022) · European journal of medical research · doi:10.1186/s40001-022-00710-2 · Cited by 23
Audu, R., Stafford, K. A., Steinhardt, L. C., Musa, A. Z., Iriemenam, N. C., Ilori, E. A., Blanco, N., Mitchell, A. B., Hamada, Y., Moloney, M., et al. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000363 · Cited by 20
Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
Kshatri, J. S., Bhattacharya, D., Kanungo, S., Giri, S., Palo, S. K., Parai, D., Turuk, J., Mansingh, A., Choudhary, H. R., Pattnaik, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-89877-y · Cited by 22
Talla, C., Loucoubar, C., Roka, J. L., Barry, M. A., Ndiaye, S., Diarra, M., Thiam, M. S., Faye, O., Dia, M., Diop, M. M., et al. (2021) · IJID Regions · doi:10.1016/j.ijregi.2022.02.007 · Cited by 22
The Missing Millions: Uncovering the Burden of Covid‐19 Cases and Deaths in the African Region
McKay, T., Robinson, R. S., Musungu, S., Padi‐Adjirackor, N. A., & Angotti, N. (2024) · Population and Development Review · doi:10.1111/padr.12608 · Cited by 21
McClarty, L. M., Lazarus, L., Pavlova, D., Reza‐Paul, S., Balakireva, O. M., Kimani, J., Tarasova, T., Lorway, R. R., Becker, M., & McKinnon, L. R. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00591-w · Cited by 20
SARS-CoV-2 prevalence and immunity: a hospital-based study from Malawi
Meinus, C., Singer, R., Nandi, B., Jagot, O., Becker‐Ziaja, B., Karo, B., Mvula, B., Jansen, A., Baumann, J., & Schultz, A. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.12.336 · Cited by 19
Lightening the viral load to lessen covid-19 severity
Burgess, S., Smith, D., Kenyon, J. C., & Gill, D. (2020) · BMJ · doi:10.1136/bmj.m4763 · Cited by 18
Emerging public health challenges during the COVID‐19 pandemic in Malawi: A review
Chiumia, I. K., Mosiwa, B. A., Nkhonjera, J., Kazanga, B., Mukondiwa, A., Twalibu, A., Phuka, J. C., & Lucero‐Prisno, D. E. (2022) · Public Health Challenges · doi:10.1002/puh2.40 · Cited by 18
Between a hygiene rock and a hygienic hard place
Parker, W., Sarafian, J. T., Broverman, S. A., & Laman, J. D. (2021) · Evolution Medicine and Public Health · doi:10.1093/emph/eoab006 · Cited by 18
Tapela, K., Oyawoye, F. O., Olwal, C. O., Opurum, P. C., Amponsah, J. A., Segbedzi, K. A. L., Tetteh, B. E., Kumi-Ansah, F., Mutungi, J. K., Obodai, E., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02571-2 · Cited by 18
Benn, C. S., Salinha, A., Mendes, S., Cabral, C. H. P. D. S., Martins, C. L., Nielsen, S., Fisker, A. B., Schaltz‐Buchholzer, F., Jørgensen, C. S., & Aaby, P. (2021) · Public Health · doi:10.1016/j.puhe.2021.11.013 · Cited by 15
Tadese, E. B., Endris, A. A., Solomon, H., Alayu, M., Kebede, A., Eshetu, K., Teka, G., Eskinder, B., Ahmed, J., Abayneh, S., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.08.028 · Cited by 16
Bakshi, A., Doren, A. V., Maser, C., Aubin, K., Stewart, C., Soileau, S., Friedman, K., & Williams, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264336 · Cited by 14
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology
Ochola, L. B., Ogongo, P., Mbugua, S. M., Gitaka, J., & Suliman, S. (2021) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2021.10.005 · Cited by 13
Arnaldo, P., Mabunda, N. J., Young, P. W., Tran, T. M., Sitoe, N. E., Chelene, I., Nhanombe, A., Ismael, N., Júnior, A., Cubula, B., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac516 · Cited by 13
Nzoghe, A. M., Leboueny, M., Kamgaing, É. K., Siawaya, A. C. M., Bongho, E. C., Ndjindji, O. M., Padzys, G.-S., Ndeboko, B., Ategbo, S., & Siawaya, J. F. D. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05570-3 · Cited by 12
SARS-CoV-2 serosurveys in low-income and middle-income countries
Mugunga, J. C., Tyagi, K., Bernal-Serrano, D., Correa, N. E., Iberico, M., Kateera, F., Leandre, F. R., Murray, M. B., Suffrin, J. C. D., & Hedt‐Gauthier, B. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00188-4 · Cited by 12
Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020
George, J. A., Khoza, S. P., Mayne, E. S., Dlamini, S., Kone, N., Jassat, W., Chetty, K., Centner, C. M., Pillay, T., Maphayi, M. R., et al. (2021) · South African Medical Journal · doi:10.7196/samj.2021.v111i11.15669 · Cited by 11
Mangal, T. D., Whittaker, C., Nkhoma, D., Ng’ambi, W. F., Watson, O. J., Walker, P. G. T., Ghani, A. C., Revill, P. A., Colbourn, T., Phillips, A. N., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045196 · Cited by 10
Masood, K. I., Qaiser, S., Abidi, S. H., Khan, E., Mahmood, S. F., Hussain, A., Ghous, Z., Imtiaz, K., Ali, N. B., Hasan, M. S., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08829-1 · Cited by 9
Low COVID-19 impact in Africa: The multifactorial Nexus
Udoakang, A. J., Oboh, M. A., Henry-Ajala, A. N., Anyigba, C. A., Omoleke, S. A., Amambua‐Ngwa, A., Paemka, L., Awandare, G. A., & Quashie, P. K. (2021) · Open Research Africa · doi:10.12688/aasopenres.13261.1 · Cited by 10
Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study
Grenfell, R. F. Q., & Oyeyemi, O. T. (2022) · Pathogens and Global Health · doi:10.1080/20477724.2022.2091862 · Cited by 10
Hout, M. C. V. (2022) · Journal of Human Rights Practice · doi:10.1093/jhuman/huac050 · Cited by 9
Awandu, S. S., Ochieng, A. O., Onyango, B., Magwanga, R. O., Were, P., Ochung’, A. A., Okumu, F. O., Oloo, M. A., Katieno, J. S., Lidechi, S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272751 · Cited by 9
Stead, D., Adeniyi, O. V., Singata‐Madliki, M., Abrahams, S., Batting, J. R., Jelliman, E., & Parrish, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058761 · Cited by 9
Ciccone, E. J., Zhu, D., Gunderson, A. K., Hawke, S., Ajeen, R., Lodge, E. K., Shook‐Sa, B. E., Abernathy, H., Garrett, H. E., King, E., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae009 · Cited by 9
COVID-19 in Africa: preexisting immunity and HIV
Snyman, J., Sanders, E. J., & Ndung’u, T. (2021) · AIDS · doi:10.1097/qad.0000000000003079 · Cited by 8
Feikin, D. R., Widdowson, M., & Mulholland, K. (2020) · Pathogens · doi:10.3390/pathogens9100838 · Cited by 7
Banda, L., Ho, A. Y. W., Kasenda, S., Read, J. M., Jewell, C., Price, A., Mclean, E. M., Dube, A. L. N., Chaima, D., Samikwa, L., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.10.020 · Cited by 7
Kusi, K. A., Frimpong, A., Partey, F. D., Lamptey, H., Amoah, L. E., & Ofori, M. F. (2021) · Open Research Africa · doi:10.12688/aasopenres.13196.1 · Cited by 6
Kusi, K. A., Frimpong, A., Partey, F. D., Lamptey, H., Amoah, L. E., & Ofori, M. F. (2021) · Open Research Africa · doi:10.12688/aasopenres.13196.3 · Cited by 11
Impouma, B., Mboussou, F., Shahpar, C., Wolfe, C. M., Farham, B. L., Williams, G. S., Karamagi, H. C., Ngom, R., Nsenga, N., Flahault, A., et al. (2021) · Epidemiology and Infection · doi:10.1017/s0950268821002417 · Cited by 7
Risk Factors for COVID-19 infection among Hospital Healthcare Workers, Sierra Leone, 2020
Squire, J. S., Dadzie, D., Nyarko, K. M., Danso‐Appiah, A., Kaburi, B. B., Noora, C. L., Vandi, M. A., Ameme, D. K., Kenu, E., & Sackey, S. O. (2022) · Journal of Interventional Epidemiology and Public Health · doi:10.37432/jieph.supp.2022.5.1.04.4 · Cited by 5
COVID-19 Risk Communication and Community Engagement (RCCE) in Malawi: Challenges and Response
Maganga, C. F., Ngwira, F. F., Gondwe, G., Nyang’wa, B., & Kunkumbira, T. (2023) · Health Promotion Practice · doi:10.1177/15248399231216725 · Cited by 5
Alber, D., Haidara, F. C., Luoma, J., Adubra, L., Ashorn, P., Ashorn, U., Badji, H., Cloutman-Green, E., Diallo, F., Ihamuotila, R., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060367 · Cited by 4
COVID-19- Related Stigma in COVID-19 Survivors in Kampala, Uganda: A Qualitative StudyPreprint
Kabunga, A. (2021) · Research Square · doi:10.21203/rs.3.rs-150583/v1 · Cited by 4
Controlling the first wave of the COVID–19 pandemic in Malawi: results from a panel studyPreprint
Banda, J., Dube, A. L. N., Brumfield, S., Crampin, A. C., Reniers, G., Amoah, A. S., & Helleringer, S. (2021) · medRxiv · doi:10.1101/2021.02.21.21251597 · Cited by 4
Controlling the first wave of the COVID–19 pandemic in Malawi: Results from a multi-round study
Banda, J., Dube, A. L. N., Brumfield, S., Crampin, A. C., Reniers, G., Amoah, A. S., & Helleringer, S. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003474 · Cited by 6
Akinseinde, S. A., Kosemani, S., Osuolale, E., Cesare, N., Pellicane, S., & Nsoesie, E. O. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291118 · Cited by 3
Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women and their infants in Uganda and Malawi
Hookham, L., Cantrell, L., Cose, S., Freyne, B., Gadama, L. A., Imede, E., Kawaza, K., Lissauer, S., Musoke, P., Nankabirwa, V., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0290913 · Cited by 4
Seroprevalence of SARS‐CoV‐2 in 10 Regional Capitals of Cameroon, October–December 2020
Sachathep, K. K., Duong, Y. T., Reid, G. A., Dokubo, E. K., Shang, J. D., Ndongmo, C. B., Gabriel, E., Tharp, G., Dimite, L. E., N'Dir, A., et al. (2024) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13267 · Cited by 3
Using genomics to improve preparedness and response of future epidemics or pandemics in Africa
Chaguza, C., Nyaga, M. M., Mwenda, J. M., Esona, M. D., & Jere, K. C. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30169-5 · Cited by 3
Self-citationKumar, D., Bhota, S., Gupta, G., Sood, T., Kanwal, S., Jaryal, S. C., & Raina, S. K. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_288_21 · Cited by 3
Henrion, M. (2020) · medRxiv · doi:10.1101/2020.12.01.20241919 · Cited by 3
Self-citationIntense and Mild Wave of COVID-19 in the Gambia: A Cohort AnalysisPreprint
Roca, A., & MRCG/GG COVID-19 working group (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3736177 · Cited by 3
Genomic epidemiology of SARS-CoV-2 infections in The Gambia, March 2020 to Jan 2022Preprint
Kanteh, A., Jallow, H. S., Manneh, J., Sanyang, B., Kujabi, M. A., Ndure, S. L., Jarju, S., Sey, A. P., Dabiri Damilare, K., Bah, Y., et al. (2022) · medRxiv · doi:10.1101/2022.09.07.22278739 · Cited by 3
Saleh, S. (2021) · Frontiers in Sociology · doi:10.3389/fsoc.2021.776968 · Cited by 2
Ogunleye, V. O., Oluwalusi, O. P., Popoola, O. A., Kehinde, A. O., Adekanmbi, O. A., Udofia, I. P., Agbi, S., Akintayo, I. J., Ajiboye, J. J., Bamidele, F., et al. (2022) · Journal of Public Health in Africa · doi:10.4081/jphia.2022.1720 · Cited by 2
Pre-vaccination seroprevalence of SARS-CoV-2 antibodies in the Volta Region, Ghana
Aninagyei, E., Ayivor-Djanie, R., Gyamfi, J., Aboagye, M. E., Kpeli, G. S., Ampofo, W., Gyapong, J. O., & Duedu, K. O. (2024) · IJID Regions · doi:10.1016/j.ijregi.2024.01.007 · Cited by 2
Oleribe, O. O., Taylor-Robinson, S. D., & Taylor-Robinson, A. W. (2024) · Public Health in Practice · doi:10.1016/j.puhip.2024.100486 · Cited by 2
Comparable exposure to SARS-CoV-2 in young children and healthcare workers in Zambia
Laban, N. M., Bosomprah, S., Musukuma, K., Simuyandi, M., Iyer, S. S., Ng’ombe, H., Muchimba, M., Chauwa, A., Tigere, S. F., Chisenga, C. C., et al. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16759.1 · Cited by 1
Ogero, M. O., Isaaka, L., Lucinde, R. K., Mumelo, L., Gathuri, H., Kimego, D., Njoroge, T., Mbevi, G., Wanyama, C. W., Otiende, M., et al. (2024) · Wellcome Open Research · doi:10.12688/wellcomeopenres.21170.1 · Cited by 2
Zaniku, H., Aron, M., Vrkljan, K., Tyagi, K., Ndambo, M., Banda, G. M., Nyirongo, R., Mphande, I., Mailosi, B. G. D., Talama, G., et al. (2022) · medRxiv · doi:10.3390/ijerph20105877 · Cited by 1
Geographic heterogeneity of SARS-CoV-2 circulation in Abidjan, Ivory Coast: a prospective study
Doumbia, M., Sévédé, D., Kouakou, V. A., & Pineau, P. (2024) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.17675 · Cited by 1
The Lived Social Experience of COVID-19 Survivors in Southwestern Nigeria
Uzobo, E., Nwanwene, I., & Ojo, T. F. (2022) · Journal of Social Behavioral and Health Sciences · doi:10.5590/jsbhs.2022.16.1.15 · Cited by 1
Madinga, J. N., Kingebeni, P. M., Nkuba-Ndaye, A., Baketana, L., Matungulu-Biyala, E., Lupola, P. M., Seghers, C.-A., Smekens, T., Ariën, K. K., Damme, W. V., et al. (2024) · Journal of Health Population and Nutrition · doi:10.1186/s41043-024-00536-0 · Cited by 1
Patamatamkul, S., Rawangban, P., Prommongkol, B., & Potongcamphan, M. (2022) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001150 · Cited by 1
Hookham, L., Cantrell, L., Cose, S., Freyne, B., Gadama, L. A., Imede, E., Kawaza, K., Lissauer, S., Musoke, P., Nankabirwa, V., et al. (2023) · medRxiv · doi:10.1101/2023.08.19.23294311 · Cited by 1
Bello, S. O., Igumbor, E. U., Deeni, Y., Ochu, C. L., & Popoola, M. A. (2020) · medRxiv · doi:10.1101/2020.09.13.20193524
Diagne, C. T., Ndiaye, O., Talla, C., Dia, F., Faye, R., Diouf, B., Tall, B., Mbengue, A., Diop, M. M., Diallo, K. M., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3916756
Madinga, J. N., Kingebeni, P. M., Nkuba-Ndaye, A., Baketana, L., Matungulu, É., Mutombo, P. K., Ariën, K. K., Damme, W. V., Kalk, A., Peeters, M., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4010766
Erondu, N. A., Ali, S. A., Ali, M., & Agbla, S. C. (2020) · doi:10.2196/preprints.26347
Ofori, S. K., Schwind, J. S., Sullivan, K. L., Chowell, G., Cowling, B. J., & Fung, I. C. (2022) · medRxiv · doi:10.1101/2022.07.09.22277456
Mwale, S. E., Chisale, M., Chimenya, M., Tandwe, T. N. G., Chapeta, Y., Nkosi, M. M., Nyambalo, B. W., Ngonga, J., Munyenyembe, P., Kayange, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1870665/v1
SARS-CoV-2 Seroprevalence in Malawian Breastfed Infants between February 2020 And May 2021Preprint
Baroncelli, S., Galluzzo, C. M., Orlando, S., Mphwere, R., Kavalo, T., Luhanga, R., Amici, R., Floridia, M., Andreotti, M., Scarcella, P., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4103025
Masat, S., & Koç, Z. (2023) · Ege Üniversitesi Hemşirelik Fakültesi Dergisi · doi:10.53490/egehemsire.1095696
Metadata
- Authors
- Chibwana, M. G., Jere, K. C., Kamng'ona, R., Mandolo, J., Katunga-Phiri, V., Tembo, D., Mitole, N., Musasa, S., Sichone, S., Lakudzala, A., Sibale, L., Matambo, P., Kadwala, I., Byrne, R. L., Mbewe, A., Henrion, M. Y. R., Morton, B., Phiri, C., Mallewa, J., Mwandumba, H. C., Adams, E. R., Gordon, S. B., & Jambo, K. C.
- Affiliations
- Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MW)
- University of Liverpool (GB)
- University of Malawi (MW)
- Liverpool School of Tropical Medicine (GB)
- Ministry of Health (MW)
- Corresponding author
- Gordon, Stephen B.
- ORCID
- Venue
- Wellcome Open Research
- Publisher
- F1000 Research Ltd
- Published
- 2020-08-25
- Volume
- 5
- Pages
- 199
- ISSN
- 2398-502X (ISSN-L)
- PMC
- PMC7402052
- OpenAlex
- W3046449642
- Cited by
- 110
- References
- 15
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 13 · 2023: 9 · 2022: 24 · 2021: 44 · 2020: 15
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Update notices
- new_version (2020-12-18)
- Open access
- gold
- doi.org
- Licence
- Locations
- Wellcome Open Research (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- Figshare (submittedVersion, cc-by)
- Figshare (cc-by)
- Funders
- Medical Research Council (MR/T008822/1)
- National Institutes of Health (U01AI131348)
- National Institute for Health Research (3477609, 200907)
- Wellcome Trust (201945, 220764, 206545, 211433)
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Keywords
- SARS-CoV-2, COVID-19 pandemic, seroprevalence, healthcare workers, IgG, underreporting of deaths, epidemic trajectory, epidemic modeling, Blantyre, sub-Saharan Africa
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review